Vasopressin V2 receptor (V2R, AVPR2) neurons express the Gs-coupled receptor for arginine vasopressin (AVP) that mediates the antidiuretic effects of this posterior pituitary hormone. While V2 receptors are predominantly expressed in renal collecting duct principal cells where they regulate water reabsorption, emerging evidence has identified central nervous system expression in specific neuronal populations with roles in social behavior, memory, and autonomic regulation. V2R dysfunction contributes to fluid-electrolyte disorders in neurodegenerative diseases, particularly the syndrome of inappropriate antidiuretic hormone (SIADH) observed in Alzheimer's disease and Parkinson's disease.[1]
Understanding V2 receptor biology bridges renal physiology with neuroendocrine dysfunction in neurological disorders.
| Location | Expression Level | Function |
|---|---|---|
| Renal principal cells | High (primary) | Aquaporin-2 insertion, water reabsorption |
| Inner medulla | Moderate | Urinary concentration |
| Hypothalamus | Low | Autoregulation of AVP release |
| Limbic structures | Very low | Social behavior, memory |
| Choroid plexus | Low | CSF production regulation |
Central V2R expression has been reported in:
| Feature | Detail |
|---|---|
| Gene | AVPR2 (Xq28) |
| Protein | 371 amino acids |
| Structure | 7-transmembrane GPCR |
| G protein | Gs/olf |
| Second messenger | cAMP, PKA activation |
| Chromosome | X chromosome (X-linked inheritance) |
Renal principal cells:
CNS neurons (putative):
SIADH is common in neurodegenerative disorders:
| Disorder | SIADH Prevalence | Mechanism |
|---|---|---|
| Alzheimer's disease | 10-20% | Hypothalamic degeneration, medications |
| Parkinson's disease | 5-15% | Autonomic dysfunction, drug-induced |
| Head trauma | 30-50% | Direct hypothalamic injury |
| Stroke | 10-25% | Hypothalamic/pituitary damage |
| Brain tumors | Variable | Mass effect, infiltration |
Clinical features:
V2R-related abnormalities in AD include:
Hyponatremia consequences:
PD patients experience V2R-related issues:
AVPR2 mutations cause X-linked nephrogenic DI:
V2R expression and function are regulated by:
Tolvaptan:
Conivaptan:
Clinical uses:
Neurodegenerative disease applications:
| Approach | V2R Target | Use Case |
|---|---|---|
| Fluid restriction | Reduces stimulus | First-line, mild |
| Tolvaptan | Antagonist | Moderate-severe SIADH |
| Hypertonic saline | Bypass receptor | Severe symptoms |
| Urea | Osmotic effect | Chronic management |
Vasopressin V2 receptor neurons mediate the water-retaining effects of antidiuretic hormone through renal principal cell aquaporin-2 regulation. Central V2R expression may contribute to social behavior and memory circuits. V2R dysfunction underlies SIADH, a common complication of neurodegenerative diseases, trauma, and medications. Vaptans like tolvaptan provide targeted therapy by antagonizing V2 receptors to promote free water excretion. Understanding V2R biology is essential for man
Verbalis JG. Disorders of water balance. 2022. ↩︎
Purba JS, et al. Decreased vasopressin message in the hypothalamus of Alzheimer's disease patients. Exp Neurol. 1993. ↩︎
Schrier RW, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006. ↩︎